首页 > 最新文献

International Journal of Ayurvedic Medicine最新文献

英文 中文
Evaluation of acute toxicity of Rasaparpati - An Ayurvedic mercurial compound in Albino rats 阿育吠陀汞化合物Rasaparpati对白化病大鼠的急性毒性评价
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3695
Lily Meher, Kshirod Kumar Ratha, Arun Kumar Das
Background This study aimed to investigate the preparation process of Rasaparpati, an Ayurvedic medicine containing Mercury that is commonly used to treat various ailments. The dangers of using Mercury as a therapeutic agent are acknowledged, and Ayurveda emphasizes purifying heavy metals before human use. The present study assessed the acute toxicity of Rasaparpati in albino rats to ensure its safe consumption. Methodology Following ethical guidelines and O.E.C.D. (423) protocol, Rasaparpati was prepared traditionally, and an acute toxicity study was conducted. Two groups of female Wistar rats were administered 300mg/kg and 2000mg/kg of Rasaparpati, and their behavioral changes, signs of toxicity, and mortality were closely monitored. Hematological, biochemical, and histopathological parameters were also examined for any changes. The data obtained were analyzed and evaluated using an unpaired t-test, with p < 0.05 considered significant. Results No deaths were observed following the administration of Rasaparpati in an acute toxicity study. There were no hematological or biochemical toxicity indications, even at ten time the therapeutic dose. However, the histopathological analysis revealed mild changes likely to heal and repair. These non-specific and reversible changes in rat cells suggest similar outcomes in human cells. Conclusions The acute toxicity study of Rasaparpati suggests its safety for animal use, indicating potential safety for human consumption. No adverse effects or mortality were observed, even at a dosage ten times higher than the therapeutic dose. However, more extensive research with larger sample sizes and control groups is recommended.
背景# x0D;本研究旨在研究Rasaparpati的制备过程,Rasaparpati是一种含有汞的阿育吠陀药物,通常用于治疗各种疾病。使用汞作为治疗剂的危险是公认的,阿育吠陀强调在人类使用之前净化重金属。本研究评估了白化大鼠的急性毒性,以确保其安全食用。 方法# x0D;按照伦理准则和oecd(423)协议,Rasaparpati采用传统方法制备,并进行了急性毒性研究。两组雌性Wistar大鼠分别给予300mg/kg和2000mg/kg的Rasaparpati,密切监测其行为变化、毒性体征和死亡率。同时检查血液学、生化和组织病理学参数是否有任何变化。使用非配对t检验对获得的数据进行分析和评估,p <0.05认为显著。 结果# x0D;在急性毒性研究中,未观察到Rasaparpati给药后死亡。即使在治疗剂量的10倍,也没有血液学或生化毒性指征。然而,组织病理学分析显示轻微的变化可能愈合和修复。大鼠细胞中的这些非特异性和可逆性变化表明人类细胞也有类似的结果。结论# x0D;急性毒性研究表明其对动物使用是安全的,提示人类食用的潜在安全性。即使剂量比治疗剂量高10倍,也未观察到不良反应或死亡。然而,建议进行更广泛的研究,采用更大的样本量和对照组。
{"title":"Evaluation of acute toxicity of Rasaparpati - An Ayurvedic mercurial compound in Albino rats","authors":"Lily Meher, Kshirod Kumar Ratha, Arun Kumar Das","doi":"10.47552/ijam.v14i3.3695","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3695","url":null,"abstract":"Background&#x0D; This study aimed to investigate the preparation process of Rasaparpati, an Ayurvedic medicine containing Mercury that is commonly used to treat various ailments. The dangers of using Mercury as a therapeutic agent are acknowledged, and Ayurveda emphasizes purifying heavy metals before human use. The present study assessed the acute toxicity of Rasaparpati in albino rats to ensure its safe consumption.&#x0D; Methodology&#x0D; Following ethical guidelines and O.E.C.D. (423) protocol, Rasaparpati was prepared traditionally, and an acute toxicity study was conducted. Two groups of female Wistar rats were administered 300mg/kg and 2000mg/kg of Rasaparpati, and their behavioral changes, signs of toxicity, and mortality were closely monitored. Hematological, biochemical, and histopathological parameters were also examined for any changes. The data obtained were analyzed and evaluated using an unpaired t-test, with p < 0.05 considered significant.&#x0D; Results&#x0D; No deaths were observed following the administration of Rasaparpati in an acute toxicity study. There were no hematological or biochemical toxicity indications, even at ten time the therapeutic dose. However, the histopathological analysis revealed mild changes likely to heal and repair. These non-specific and reversible changes in rat cells suggest similar outcomes in human cells.&#x0D; Conclusions&#x0D; The acute toxicity study of Rasaparpati suggests its safety for animal use, indicating potential safety for human consumption. No adverse effects or mortality were observed, even at a dosage ten times higher than the therapeutic dose. However, more extensive research with larger sample sizes and control groups is recommended.&#x0D;","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New validated Ultra High Performance Liquid Chromatographic method for Estimation of Quercetin 超高效液相色谱法测定槲皮素含量的新方法
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3710
Mitali Y Kubade, Priya Shetti, Sachin Gudasi
Background: A new Ultra performance liquid chromatographic analytical method was developed and validated for estimation of Quercetin in bulk powder. The reverse phase chromatographic elution using UPLC was carried out in gradient mode on C-18 column (Phenomenex Luna 5 µm, 150 mm X 4.6 mm) as stationary phase utilizing a mobile phase composed of Acetonitrile: 0.1 % formic acid buffer (50:50 v/v) with a flow rate of 1 ml/min and injection volume of 10µl. The analysis was performed at temperature of 400C and detection of eluent was carried out using photo diode array at 371 nm. The newly developed Ultra performance liquid chromatography method was validated in terms of linearity and range, system suitability, specificity, precision, sensitivity, robustness, ruggedness and accuracy as per ICH guidelines. Results: The retention time of quercetin was found to be at 3.9 min with total run time of analysis is 7 minutes. The linearity was observed between the concentration ranges from 0.5 to 16µg/ml with correlation coefficient 0.999. The precision assays values were found to be less than 2% for both the drugs. The Limit of Detection and Limit of Quantification were 0.47µg/ml and 1.44µg/ml for Quercetin. The mean percentage recovery values were found to be within the range of 90-110 %. Conclusion: The proposed method was found to be simple, specific, precise, sensitive, robust, rugged and accurate and can be used for routine quality control analysis of Quercetin.
背景:建立了一种新的超高效液相色谱法测定散装粉末中槲皮素的含量。以C-18色谱柱(Phenomenex Luna 5µm, 150 mm X 4.6 mm)为固定相,流动相为乙腈:0.1%甲酸缓冲液(50:50 v/v),流速为1 ml/min,进样量为10µl,采用UPLC梯度模式进行反相色谱洗脱。分析温度为400℃,洗脱液检测采用光电二极管阵列,波长为371 nm。根据ICH指南,新开发的超高效液相色谱方法在线性和范围、系统适用性、特异性、精密度、灵敏度、稳健性、耐用性和准确性方面进行了验证。结果:槲皮素的保留时间为3.9 min,分析总运行时间为7 min。浓度在0.5 ~ 16µg/ml范围内呈线性关系,相关系数为0.999。两种药物的精密度测定值均小于2%。槲皮素的检出限和定量限分别为0.47µg/ml和1.44µg/ml。平均回收率在90 ~ 110%之间。结论:该方法简便、专属性好、精密度高、灵敏度高、鲁棒性好、坚固耐用、准确度高,可用于槲皮素的常规质量控制分析。
{"title":"New validated Ultra High Performance Liquid Chromatographic method for Estimation of Quercetin","authors":"Mitali Y Kubade, Priya Shetti, Sachin Gudasi","doi":"10.47552/ijam.v14i3.3710","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3710","url":null,"abstract":"Background: A new Ultra performance liquid chromatographic analytical method was developed and validated for estimation of Quercetin in bulk powder. The reverse phase chromatographic elution using UPLC was carried out in gradient mode on C-18 column (Phenomenex Luna 5 µm, 150 mm X 4.6 mm) as stationary phase utilizing a mobile phase composed of Acetonitrile: 0.1 % formic acid buffer (50:50 v/v) with a flow rate of 1 ml/min and injection volume of 10µl. The analysis was performed at temperature of 400C and detection of eluent was carried out using photo diode array at 371 nm. The newly developed Ultra performance liquid chromatography method was validated in terms of linearity and range, system suitability, specificity, precision, sensitivity, robustness, ruggedness and accuracy as per ICH guidelines. Results: The retention time of quercetin was found to be at 3.9 min with total run time of analysis is 7 minutes. The linearity was observed between the concentration ranges from 0.5 to 16µg/ml with correlation coefficient 0.999. The precision assays values were found to be less than 2% for both the drugs. The Limit of Detection and Limit of Quantification were 0.47µg/ml and 1.44µg/ml for Quercetin. The mean percentage recovery values were found to be within the range of 90-110 %. Conclusion: The proposed method was found to be simple, specific, precise, sensitive, robust, rugged and accurate and can be used for routine quality control analysis of Quercetin.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of Swa Anguli Pramana in Health Assessment: Insights from Cross-Sectional Study on Aayama Relationship Swa Anguli Pramana在健康评估中的重要性:来自Aayama关系横断面研究的见解
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3661
Akhil Babu T, Rupali R Bawa, Nitin Chandurkar, Pavan R Gulhane
Introduction: The anthropometry techniques used today share similarities with the method described in Ayurveda by the acharyas. Ayurvedic science adopts a more personalized approach to measurement, taking into account individual variations in the body proportions for a greater precision in assessing each body part. In contrast to the modern approach, which relies on a generalized view, ayurvedic science offers significant advantages. Method: Survey conducted among 400 individuals to determine the correlation between swa anguli pramana (measurement of the width of the proximal phalanx of the middle finger in the palmar aspect) and aayama (height). Result: The study found that there was a change in the average swa anguli pramana values, which caused a noteworthy difference in the aayama of the individuals. The study clearly indicates that, swa anguli pramana is positively associated with height of individual. Discussion: However, the study does not invalidate the swa anguli pramana measurement technique or elevate the contemporary day standard metric system above it. The existing metric system has limitations, such as variations with changes in gender, race, and area, whereas swa anguli standards are individualistic and not impacted by these aspects. The study suggests that revalidation of the pramanas is required, but considering it as a standard system of measurement remains relevant.
简介:今天使用的人体测量技术与阿育吠陀中阿查里亚人所描述的方法有相似之处。阿育吠陀科学采用了一种更加个性化的测量方法,考虑到身体比例的个体变化,以更精确地评估每个身体部位。与依赖于广义观点的现代方法相比,阿育吠陀科学具有显著的优势。方法:对400名个体进行调查,以确定swa anguli pramana(中指掌侧近端指骨宽度的测量)与aayama(身高)之间的相关性。结果:研究发现,swa anguli的平均pramana值发生了变化,导致个体的ayama有显著差异。该研究清楚地表明,swa anguli pramana与个体身高呈正相关。讨论:然而,这项研究并没有使swa anguli pramana测量技术无效,也没有将当代标准公制提升到它之上。现有的公制体系有局限性,例如随着性别、种族和地区的变化而变化,而斯瓦安古里的标准是个人主义的,不受这些方面的影响。该研究表明,需要重新验证pramanas,但将其视为标准测量系统仍然是相关的。
{"title":"Importance of Swa Anguli Pramana in Health Assessment: Insights from Cross-Sectional Study on Aayama Relationship","authors":"Akhil Babu T, Rupali R Bawa, Nitin Chandurkar, Pavan R Gulhane","doi":"10.47552/ijam.v14i3.3661","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3661","url":null,"abstract":"Introduction: The anthropometry techniques used today share similarities with the method described in Ayurveda by the acharyas. Ayurvedic science adopts a more personalized approach to measurement, taking into account individual variations in the body proportions for a greater precision in assessing each body part. In contrast to the modern approach, which relies on a generalized view, ayurvedic science offers significant advantages. Method: Survey conducted among 400 individuals to determine the correlation between swa anguli pramana (measurement of the width of the proximal phalanx of the middle finger in the palmar aspect) and aayama (height). Result: The study found that there was a change in the average swa anguli pramana values, which caused a noteworthy difference in the aayama of the individuals. The study clearly indicates that, swa anguli pramana is positively associated with height of individual. Discussion: However, the study does not invalidate the swa anguli pramana measurement technique or elevate the contemporary day standard metric system above it. The existing metric system has limitations, such as variations with changes in gender, race, and area, whereas swa anguli standards are individualistic and not impacted by these aspects. The study suggests that revalidation of the pramanas is required, but considering it as a standard system of measurement remains relevant.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135788414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Study of Maricha Kshaudra Yoga in the Management of Vataja kasa (dry cough) 玛丽查按摩瑜伽治疗干咳的临床研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3511
Manojkumar Chaudhari, Yogita Chaudhari, Priyanka Dawane, Anand Madgundi, Devdatta Deshmukh
One of the oldest holistic medicinal systems in the world is Ayurveda, which has explained comprehensive pathophysiology of different diseases along with its management. One of the most significant and typical respiratory conditions listed in Ayurveda is Vataja kasa. It is mainly characterized by shushka kasa (dry cough), swarabheda (hoarseness in voice), kshinabala (weakness), hritshoola (pain in the chest), parshwashoola (pain in flanks), udarashoola (pain in abdomen), shirashoola (headache), etc. Due to outside factors including population growth, contamination of the environment, industrialization, and urbanisation, it has a growing prevalence throughout time. It is one of the typical complaints and is also a symptom of many Pranvah strotasa (respiratory system) disorders. Classics of Ayurveda, has elaborately Kasa as a distinct disease with its diagnostic details and plan of management. Even though multiple options are there for its management, Maricha kshaudra yoga, prescribed by Sushruta Samhita was not yet tested. Therefore, an effort was made to research the effectiveness of Maricha kshaudra yoga, a trial medicine, in the treatment of Vataja Kasa. Data was collected on the first, seventh, and fourteenth days after the medicine was administered, and it was determined to have significant efficacy.
阿育吠陀是世界上最古老的整体医疗系统之一,它解释了不同疾病的综合病理生理学及其管理。阿育吠陀列出的最重要和最典型的呼吸系统疾病之一是Vataja kasa。它的主要特征是shushka kasa(干咳)、swarabheda(声音嘶哑)、kshinabala(虚弱)、hitshoola(胸部疼痛)、parshwashoola(两侧疼痛)、udarashoola(腹部疼痛)、shirashoola(头痛)等。由于包括人口增长、环境污染、工业化和城市化在内的外部因素,它在整个时间里越来越普遍。它是一种典型的抱怨,也是许多呼吸系统紊乱的症状。经典的阿育吠陀,已经详细阐述了卡萨作为一种独特的疾病,其诊断细节和管理计划。尽管有多种管理方法,但由苏什鲁塔·萨姆希塔(Sushruta Samhita)规定的玛丽查·克绍德拉瑜伽(Maricha kshaudra yoga)尚未经过测试。因此,人们努力研究Maricha kshaudra瑜伽(一种试验药物)在治疗Vataja Kasa方面的有效性。在给药后第1天、第7天、第14天采集数据,确定疗效显著。
{"title":"Clinical Study of Maricha Kshaudra Yoga in the Management of Vataja kasa (dry cough)","authors":"Manojkumar Chaudhari, Yogita Chaudhari, Priyanka Dawane, Anand Madgundi, Devdatta Deshmukh","doi":"10.47552/ijam.v14i3.3511","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3511","url":null,"abstract":"One of the oldest holistic medicinal systems in the world is Ayurveda, which has explained comprehensive pathophysiology of different diseases along with its management. One of the most significant and typical respiratory conditions listed in Ayurveda is Vataja kasa. It is mainly characterized by shushka kasa (dry cough), swarabheda (hoarseness in voice), kshinabala (weakness), hritshoola (pain in the chest), parshwashoola (pain in flanks), udarashoola (pain in abdomen), shirashoola (headache), etc. Due to outside factors including population growth, contamination of the environment, industrialization, and urbanisation, it has a growing prevalence throughout time. It is one of the typical complaints and is also a symptom of many Pranvah strotasa (respiratory system) disorders. Classics of Ayurveda, has elaborately Kasa as a distinct disease with its diagnostic details and plan of management. Even though multiple options are there for its management, Maricha kshaudra yoga, prescribed by Sushruta Samhita was not yet tested. Therefore, an effort was made to research the effectiveness of Maricha kshaudra yoga, a trial medicine, in the treatment of Vataja Kasa. Data was collected on the first, seventh, and fourteenth days after the medicine was administered, and it was determined to have significant efficacy.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135788418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Druggability study to Probe immunomodulatory Unani plants as active Inhibitors of Pseudotyped Particle Cell Entry 探究免疫调节植物作为假型颗粒细胞进入活性抑制剂的药物性研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3765
Rajorshi Sen Gupta, Sandip Roy, Rajesh Bose, Palash Mandal
Medicinal herbs, plants and their products show revolutionized effect in modern therapeutic system. Industries used their activity as antioxidant, antitoxin, antimicrobial, immune booster and many others and use them accordingly as the prime agent to produce cosmetics, food, drug synthesis etc. Unani is one of the traditional therapeutic system which use medicinal herbs mostly for making their herbal medicines. There are several immunomodulatory herbs along with their phytochemicals are present to serve their best. Bioassay is the method of analysis to find out the potency or concentration of any substance when effect on living things. Sars Cov-2 virus and its fatal outbreak is a real threat to modern society. To perform in vitro procedure to screened out small molecule inhibitors of this malicious pseudo typed particle cell entry, Dr. Whittaker's group use this bioassay system like PubChem AID: 1479144, PubChem AID: 1479149, PubChem AID: 1479150 and PubChem AID: 1494158. This in silico study is to show the potency of the phytochemicals of traditional herbs of Unani, as if inhibitors by means of machine learning with the help of WEKA. The ADMET study and molecular docking with Mpro (6lu7 chain A) is also done to test the druggability and binding affinity of the qualified phytochemicals.
草药、植物及其制品在现代治疗体系中发挥着革命性的作用。工业利用它们的活性作为抗氧化剂、抗毒素、抗菌剂、免疫增强剂和许多其他用途,并相应地将它们用作生产化妆品、食品、药物合成等的主要剂。乌纳尼是一种传统的治疗系统,主要使用草药来制作草药。有几种免疫调节草药和它们的植物化学物质,以提供最好的服务。生物测定法是一种分析方法,用来找出任何物质对生物产生作用时的效力或浓度。Sars - Cov-2病毒及其致命爆发是对现代社会的真正威胁。为了执行体外程序来筛选这种恶意伪类型颗粒细胞进入的小分子抑制剂,Whittaker博士的团队使用PubChem AID: 1479144, PubChem AID: 1479149, PubChem AID: 1479150和PubChem AID: 1494158等生物测定系统。这项计算机研究是为了展示乌纳尼传统草药的植物化学物质的效力,就像在WEKA的帮助下通过机器学习来抑制一样。通过ADMET研究和与Mpro (6lu7 chain A)的分子对接,测试了符合条件的植物化学物质的药物亲和性和结合亲和力。
{"title":"A Druggability study to Probe immunomodulatory Unani plants as active Inhibitors of Pseudotyped Particle Cell Entry","authors":"Rajorshi Sen Gupta, Sandip Roy, Rajesh Bose, Palash Mandal","doi":"10.47552/ijam.v14i3.3765","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3765","url":null,"abstract":"Medicinal herbs, plants and their products show revolutionized effect in modern therapeutic system. Industries used their activity as antioxidant, antitoxin, antimicrobial, immune booster and many others and use them accordingly as the prime agent to produce cosmetics, food, drug synthesis etc. Unani is one of the traditional therapeutic system which use medicinal herbs mostly for making their herbal medicines. There are several immunomodulatory herbs along with their phytochemicals are present to serve their best. Bioassay is the method of analysis to find out the potency or concentration of any substance when effect on living things. Sars Cov-2 virus and its fatal outbreak is a real threat to modern society. To perform in vitro procedure to screened out small molecule inhibitors of this malicious pseudo typed particle cell entry, Dr. Whittaker's group use this bioassay system like PubChem AID: 1479144, PubChem AID: 1479149, PubChem AID: 1479150 and PubChem AID: 1494158. This in silico study is to show the potency of the phytochemicals of traditional herbs of Unani, as if inhibitors by means of machine learning with the help of WEKA. The ADMET study and molecular docking with Mpro (6lu7 chain A) is also done to test the druggability and binding affinity of the qualified phytochemicals.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Panchakarma in the Management of Spinal Canal Stenosis - A Case Study Panchakarma在椎管狭窄治疗中的作用-一个案例研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3818
Anjali G, Sangeeta T, Parappagoudra M, Dash G
Spinal canal stenosis is a painful, degenerative condition, and is localized to facets, joints, and ligamentum flavum of the vertebra which is often referred to for surgical correction. The main cause of stenosis is herniated vertebral disc. If there is no compression, the spinal canal can be referred to as narrow, but not stenotic. Certain studies have defined lumbar spinal stenosis as the narrowing of the osteo-ligamentous vertebral canal or the intervertebral foramina, which causes compression of the thecal sac or the caudal nerve roots. The narrowing may impact the entire canal or just a portion of it, but it occurs at a single vertebral level. In this condition, it may, drastically affect the quality of life due to severe pain in doing daily routine activities. In contemporary science, there is no treatment except surgical intervention which is having a high chance of complication and the chances of recurrence. Surgery is necessary when there are clinically significant motor deficiencies or symptoms of cauda equina syndrome. Based on the manifestation of clinical signs and symptoms it can be correlated with Gridhrasi, according to Ayurveda. Gridhrasi can be treated successfully by the intervention of Panchakarma procedures along with Shamana Chikitsa. Here is a case study of a patient suffering from low back pain radiating to bilateral lower limbs, stiffness, numbness, burning sensation in the bilateral sole region, and unable to walk without support, who was previously diagnosed as a case of Spinal Canal Stenosis. He was treated with a Panchakarma procedure, Shamana Chikitsa along with Physiotherapy Exercises. The patient showed marked improvement and could do daily routine activities properly.
椎管狭窄是一种疼痛的退行性疾病,并且局限于椎体的关节、关节和黄韧带,通常需要手术矫正。狭窄的主要原因是椎间盘突出。如果没有压迫,可以认为椎管狭窄,但不是狭窄。一些研究将腰椎管狭窄定义为骨韧带椎管或椎间孔狭窄,导致鞘囊或尾神经根受压。狭窄可影响整个椎管或部分椎管,但只发生在单个椎体水平。在这种情况下,由于在日常活动中剧烈疼痛,可能会严重影响生活质量。在当代科学中,除了手术治疗外,没有其他治疗方法,但手术治疗有很高的并发症和复发率。当临床上有明显的运动缺陷或马尾综合征症状时,手术是必要的。根据阿育吠陀的说法,根据临床体征和症状的表现,它可能与格拉西有关。通过Panchakarma程序和Shamana Chikitsa的干预,Gridhrasi可以成功治疗。这是一个病例研究,患者患有腰痛辐射到双侧下肢,僵硬,麻木,双侧脚底区烧灼感,没有支撑无法行走,先前诊断为椎管狭窄症。他接受了Panchakarma手术,Shamana Chikitsa和物理治疗练习。患者病情明显好转,能正常进行日常活动。
{"title":"Role of Panchakarma in the Management of Spinal Canal Stenosis - A Case Study","authors":"Anjali G, Sangeeta T, Parappagoudra M, Dash G","doi":"10.47552/ijam.v14i3.3818","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3818","url":null,"abstract":"Spinal canal stenosis is a painful, degenerative condition, and is localized to facets, joints, and ligamentum flavum of the vertebra which is often referred to for surgical correction. The main cause of stenosis is herniated vertebral disc. If there is no compression, the spinal canal can be referred to as narrow, but not stenotic. Certain studies have defined lumbar spinal stenosis as the narrowing of the osteo-ligamentous vertebral canal or the intervertebral foramina, which causes compression of the thecal sac or the caudal nerve roots. The narrowing may impact the entire canal or just a portion of it, but it occurs at a single vertebral level. In this condition, it may, drastically affect the quality of life due to severe pain in doing daily routine activities. In contemporary science, there is no treatment except surgical intervention which is having a high chance of complication and the chances of recurrence. Surgery is necessary when there are clinically significant motor deficiencies or symptoms of cauda equina syndrome. Based on the manifestation of clinical signs and symptoms it can be correlated with Gridhrasi, according to Ayurveda. Gridhrasi can be treated successfully by the intervention of Panchakarma procedures along with Shamana Chikitsa. Here is a case study of a patient suffering from low back pain radiating to bilateral lower limbs, stiffness, numbness, burning sensation in the bilateral sole region, and unable to walk without support, who was previously diagnosed as a case of Spinal Canal Stenosis. He was treated with a Panchakarma procedure, Shamana Chikitsa along with Physiotherapy Exercises. The patient showed marked improvement and could do daily routine activities properly.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variations in the severity of symptoms, DAS28, and Disability Index among different Vata predominant Deha-Prakriti individuals of Amavata (~Rheumatoid Arthritis) - An Analytical Observational Study Amavata(~类风湿关节炎)不同Vata显性Deha-Prakriti个体症状严重程度、DAS28和残疾指数的差异——一项分析性观察研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3896
Rajkumar Chinthala, Kamble S B, Bhagavathi NNL, Baghel A S
Background: Subgrouping of diseased population, based on Deha-Prakriti (DP), phenotypic classification of Ayurveda will explore the variation in the disease severity, which further aid in the management of the disease more precisely and selectively. But there is a paucity in the data generation. Amavata (~Rheumatoid Arthritis) is one of such diseases, resulting from the conglomeration of Ama and aggravated Vata gets lodged in the joints. Aim & Objective: To evaluate variations in the severity of symptoms, duration of morning stiffness, DAS28 (Disease Activity Score in 28 Joints), and Disability Index (DI) among different Vata predominant Deha-Prakriti (DP) individuals of Amavata (~Rheumatoid Arthritis). Materials & Methodology: The study was conducted among 155 clinically diagnosed patients of Amavata, who were screened for DP assessment through the CCRAS-PAS scale. Those who were found to have Vata predominant DP were sub-grouped into Single Vataja (V), Vata-Pittaja (VP), and Vata-Kaphaja (VK) DP, based on the proportion of the doshas in the output of scale. Demographic profile, the severity of the symptoms, duration of the morning stiffness, DAS28, and DI were assessed and calculated using SPSS software version 20.0, p≤0.05 was considered statistically significant. Results: Kruskal-Walli’s test revealed that Single Vata predominant DP patients were found to have severe Sandhi-shula (Joint pain) (p<0.0001), Shunatanga (Numbness of the joint) (p-value at 0.0069), Nidra-Viparyaya (Irregular sleep patterns) (p-value at 0.0012) than VP and VK DP individuals. Sandhi-Shotha (Joint swelling) (p-value at 0.0299), Angamarda (generalized body pains) (p-value at 0.0130), Alasya (laziness) (p<0.0001), Gaurava (Heaviness) (p<0.0001), and Apaka (delayed digestion) (p-value at 0.0254) were found severe in VK DP, whereas Trishna (Thirsty) (p<0.0001), Nidraviparyaya (p-value at 0.0012) were more severe in VP DP individuals. One-way ANOVA revealed that the duration of morning stiffness (2.03±0.2 hours, p-value at 0.446), DAS28 (6.85±0.175, p-value at 0.0035), and DI (1.87±0.54, p-value at 0.0003) were found significantly high in single Vataja than VP and VK Deha-Prakriti. Conclusion: The disease severity in terms of duration of morning stiffness, DAS28, and DI were found more severe in Single Vataja DP. The severity of the signs and symptoms also varied according to DP.
背景:基于Deha-Prakriti (DP)对患病人群进行亚分组,阿育吠陀的表型分类将探讨疾病严重程度的变化,进一步有助于更精确和有选择性地管理疾病。但在数据生成方面存在不足。类风湿关节炎(Amavata, ~Rheumatoid Arthritis)就是其中一种疾病,是由Ama聚集和Vata淤积在关节而引起的。的目标,目的:评价不同Vata优势型Deha-Prakriti(~类风湿关节炎)个体的症状严重程度、晨僵持续时间、DAS28(28关节疾病活动评分)和残疾指数(DI)的差异。材料,方法:本研究纳入155例临床诊断为Amavata的患者,通过CCRAS-PAS量表筛选进行DP评估。那些被发现有Vata主导DP的人被分为单一Vataja (V), Vata- pittaja (VP)和Vata- kaphaja (VK) DP,基于dosha在量表输出中的比例。统计资料、症状严重程度、晨僵持续时间、DAS28、DI采用SPSS 20.0软件进行评估和计算,p≤0.05认为有统计学意义。结果:Kruskal-Walli检验显示,与VP和VK DP个体相比,单一Vata为主的DP患者存在严重的sandi -shula(关节疼痛)(p<0.0001)、Shunatanga(关节麻木)(p值为0.0069)、Nidra-Viparyaya(睡眠模式不规则)(p值为0.0012)。Sandhi-Shotha(关节肿胀)(p值为0.0299)、Angamarda(全身疼痛)(p值为0.0130)、Alasya(懒惰)(p值为0.0001)、Gaurava(重)(p值为0.0001)和Apaka(消化迟缓)(p值为0.0254)在VK型DP中较为严重,而Trishna(口渴)(p值为0.0001)、Nidraviparyaya (p值为0.0012)在VP型DP个体中更为严重。单因素方差分析显示,Vataja组晨僵持续时间(2.03±0.2小时,p值为0.446)、DAS28(6.85±0.175,p值为0.0035)和DI(1.87±0.54,p值为0.0003)显著高于VP和VK组。结论:从晨僵持续时间、DAS28和DI来看,单Vataja DP的疾病严重程度更严重。症状和体征的严重程度也因DP而异。
{"title":"Variations in the severity of symptoms, DAS28, and Disability Index among different Vata predominant Deha-Prakriti individuals of Amavata (~Rheumatoid Arthritis) - An Analytical Observational Study","authors":"Rajkumar Chinthala, Kamble S B, Bhagavathi NNL, Baghel A S","doi":"10.47552/ijam.v14i3.3896","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3896","url":null,"abstract":"Background: Subgrouping of diseased population, based on Deha-Prakriti (DP), phenotypic classification of Ayurveda will explore the variation in the disease severity, which further aid in the management of the disease more precisely and selectively. But there is a paucity in the data generation. Amavata (~Rheumatoid Arthritis) is one of such diseases, resulting from the conglomeration of Ama and aggravated Vata gets lodged in the joints. Aim &amp; Objective: To evaluate variations in the severity of symptoms, duration of morning stiffness, DAS28 (Disease Activity Score in 28 Joints), and Disability Index (DI) among different Vata predominant Deha-Prakriti (DP) individuals of Amavata (~Rheumatoid Arthritis). Materials &amp; Methodology: The study was conducted among 155 clinically diagnosed patients of Amavata, who were screened for DP assessment through the CCRAS-PAS scale. Those who were found to have Vata predominant DP were sub-grouped into Single Vataja (V), Vata-Pittaja (VP), and Vata-Kaphaja (VK) DP, based on the proportion of the doshas in the output of scale. Demographic profile, the severity of the symptoms, duration of the morning stiffness, DAS28, and DI were assessed and calculated using SPSS software version 20.0, p≤0.05 was considered statistically significant. Results: Kruskal-Walli’s test revealed that Single Vata predominant DP patients were found to have severe Sandhi-shula (Joint pain) (p<0.0001), Shunatanga (Numbness of the joint) (p-value at 0.0069), Nidra-Viparyaya (Irregular sleep patterns) (p-value at 0.0012) than VP and VK DP individuals. Sandhi-Shotha (Joint swelling) (p-value at 0.0299), Angamarda (generalized body pains) (p-value at 0.0130), Alasya (laziness) (p<0.0001), Gaurava (Heaviness) (p<0.0001), and Apaka (delayed digestion) (p-value at 0.0254) were found severe in VK DP, whereas Trishna (Thirsty) (p<0.0001), Nidraviparyaya (p-value at 0.0012) were more severe in VP DP individuals. One-way ANOVA revealed that the duration of morning stiffness (2.03±0.2 hours, p-value at 0.446), DAS28 (6.85±0.175, p-value at 0.0035), and DI (1.87±0.54, p-value at 0.0003) were found significantly high in single Vataja than VP and VK Deha-Prakriti. Conclusion: The disease severity in terms of duration of morning stiffness, DAS28, and DI were found more severe in Single Vataja DP. The severity of the signs and symptoms also varied according to DP.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda Management in Diabetic Neuropathy vis-à-vis Prameha Upadrava–A Case Study 阿育吠陀治疗糖尿病神经病变-à-vis Prameha upadrava案例研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3696
Shweta Kodre, Jibi Varghese, Khan Aqsa Zarin, Snehal Pansare, Mohini Niware, Shreya Bhatia, Manna Mathew
Background- Diabetes mellitus (DM) in India has a higher prevalence (4.3%) than in the west (1-2%) and its complication rate is also high. Diabetic neuropathy symptoms include pain, numbness, reduced sensation of touch or oversensitivity, uncomfortable tingling and burning, skin ulcer and reduced reflexes. Diabetic neuropathies are seen in approximately 50% of individuals with long standing type 1 and type 2 DM and it often goes undiagnosed. This article presents a case study of patient with signs and symptoms of neuropathy who came with the complaint of lower back pain, bilateral lower limb pain, pricking sensation and burning sensation. Diabetic Neuropathy Examination score (DNE) along with other neuropathy screening parameters was more than 60% indicating functional loss. The Nerve conduction study also revealed demyelinating polyneuropathy. Observations and Results: The patient was treated with ayurvedic oral medication, Abhyanga (~application of medicated oils), swedana (~fomentation), and basti (~medicated enema). After ayurvedic treatment the patient showed good remission in pain, burning sensation and DNE along with all neuropathy screening were less than 20%. Patient got marked relief in all the symptoms.
背景-糖尿病(DM)在印度的患病率(4.3%)高于西方(1-2%),其并发症发生率也很高。糖尿病神经病变的症状包括疼痛、麻木、触觉减少或过度敏感、不舒服的刺痛和灼烧感、皮肤溃疡和反射减少。大约50%的长期1型和2型糖尿病患者患有糖尿病性神经病变,而且通常无法确诊。这篇文章提出了一个病例研究患者的症状和体征的神经病变谁来的主诉腰痛,双侧下肢疼痛,刺痛感和烧灼感。糖尿病神经病变检查评分(DNE)及其他神经病变筛查参数均大于60%,提示功能丧失。神经传导研究也显示脱髓鞘性多神经病变。 观察与结果:患者采用阿育吠陀口服药物、Abhyanga(应用药油)、swedana(发酵)和basti(药物灌肠)治疗。经阿育吠陀治疗后,患者疼痛、烧灼感和DNE均得到良好缓解,所有神经病变筛查均低于20%。病人的所有症状都明显减轻了。
{"title":"Ayurveda Management in Diabetic Neuropathy vis-à-vis Prameha Upadrava–A Case Study","authors":"Shweta Kodre, Jibi Varghese, Khan Aqsa Zarin, Snehal Pansare, Mohini Niware, Shreya Bhatia, Manna Mathew","doi":"10.47552/ijam.v14i3.3696","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3696","url":null,"abstract":"Background- Diabetes mellitus (DM) in India has a higher prevalence (4.3%) than in the west (1-2%) and its complication rate is also high. Diabetic neuropathy symptoms include pain, numbness, reduced sensation of touch or oversensitivity, uncomfortable tingling and burning, skin ulcer and reduced reflexes. Diabetic neuropathies are seen in approximately 50% of individuals with long standing type 1 and type 2 DM and it often goes undiagnosed. This article presents a case study of patient with signs and symptoms of neuropathy who came with the complaint of lower back pain, bilateral lower limb pain, pricking sensation and burning sensation. Diabetic Neuropathy Examination score (DNE) along with other neuropathy screening parameters was more than 60% indicating functional loss. The Nerve conduction study also revealed demyelinating polyneuropathy.&#x0D; Observations and Results: The patient was treated with ayurvedic oral medication, Abhyanga (~application of medicated oils), swedana (~fomentation), and basti (~medicated enema). After ayurvedic treatment the patient showed good remission in pain, burning sensation and DNE along with all neuropathy screening were less than 20%. Patient got marked relief in all the symptoms.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decade-Wise Rasayana prayoga in Female Reproductive Health - A Conceptual study 女性生殖健康的十年智慧拉萨耶那prayoga -一项概念性研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3830
Krishika M, Kashavva V Hiremath
The existence of life on Earth is sustained by the act of reproduction. The ultimate blessing for a couple in their lifetime is to give birth to a healthy progeny, which is only possible by the union of healthy beeja in the favorable conditions of Ritu, kshetra and ambhu. Female reproductive health plays a key role in all these four factors. Good reproductive health ensures a female to have a satisfactory and safe sexual life both physically and mentally. Rasayana prayoga during the course of dhatu utpatti in balya and madhyamavastha helps to attain the rasadi dhatu at its supreme quality. Acharya Sharangadhara quotes that the development of certain bodily characteristics attained in its pinnacle in every decade of life, starts to decline gradually after that certain period of years naturally. Rasayana therapy administered in each reproductive stage of female life may improve her reproductive health qualitatively which intern helps them to prevent various common reproductive aliments from balyatara avastha (pre-menarche) to Jara (complications after menopause). In this article, an attempt is made to collect and analyze the relevant facts from Samhitas, contemporary textbooks and e-resources and tried to conceptualize the significance of administering decade-wise Rasayana in female for improving their reproductive health.
地球上生命的存在是靠繁殖来维持的。一对夫妇一生的终极祝福是生下一个健康的后代,这只有在Ritu、kshetra和ambhu的有利条件下,健康的beeja结合才有可能。女性生殖健康在所有这四个因素中都起着关键作用。良好的生殖健康确保女性在身体和精神上都有满意和安全的性生活。在balya和madhyamavastha的禅修过程中,Rasayana prayoga有助于达到最高质量的rasadi禅修。阿查里亚·沙朗伽德罗引用说,某些身体特征的发展在生命的每十年达到顶峰,在那一段时间后自然开始逐渐下降。在女性生命的每个生殖阶段实施Rasayana疗法可以从质量上改善她们的生殖健康,这有助于她们预防各种常见的生殖营养不良,从balyatara avastha(初潮前)到Jara(更年期后的并发症)。本文试图从文献资料、当代教科书和电子资源中收集和分析相关事实,并试图概念化女性实施十年拉西亚那对改善其生殖健康的意义。
{"title":"Decade-Wise Rasayana prayoga in Female Reproductive Health - A Conceptual study","authors":"Krishika M, Kashavva V Hiremath","doi":"10.47552/ijam.v14i3.3830","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3830","url":null,"abstract":"The existence of life on Earth is sustained by the act of reproduction. The ultimate blessing for a couple in their lifetime is to give birth to a healthy progeny, which is only possible by the union of healthy beeja in the favorable conditions of Ritu, kshetra and ambhu. Female reproductive health plays a key role in all these four factors. Good reproductive health ensures a female to have a satisfactory and safe sexual life both physically and mentally. Rasayana prayoga during the course of dhatu utpatti in balya and madhyamavastha helps to attain the rasadi dhatu at its supreme quality. Acharya Sharangadhara quotes that the development of certain bodily characteristics attained in its pinnacle in every decade of life, starts to decline gradually after that certain period of years naturally. Rasayana therapy administered in each reproductive stage of female life may improve her reproductive health qualitatively which intern helps them to prevent various common reproductive aliments from balyatara avastha (pre-menarche) to Jara (complications after menopause). In this article, an attempt is made to collect and analyze the relevant facts from Samhitas, contemporary textbooks and e-resources and tried to conceptualize the significance of administering decade-wise Rasayana in female for improving their reproductive health.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network pharmacology and Molecular docking-based activity of Hemidesmus indicus (L.) R.Br. in Acute myeloid leukemia : A Computational Study 赤豆的网络药理学及分子对接活性研究R.Br。急性髓性白血病的计算研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3883
Vijay kumar Pathak
ABSTRACT Background Acute myeloid leukemia (AML) is malignancy of the stem cell precursors of the myeloid lineage occurs due to variations in genetics. Incidence rate of childhood AML in Asian population is 8.4 per million. There is no exact description of AML is Ayurveda, it can be considered into Raktapitta (~bleeding disorder) disease. Hemidesmus indicus (L.) R.Br. (~H. indicus) is described for treatment of Raktapitta. The main treatment for AML is chemotherapy, and patient are searching for Ayurvedic medicines. Hence attempt is made for evaluating activity of H. indicus in AML. Objective To establish link for therapeutic activity of H. indicus in AML using Network pharmacology and molecular docking study. Materials and methods Active compound from root of H. indicus was retrieved from phytochemical based IMPPAT database. ADME (absorption, distribution, metabolism and excretion) study of retrieved active compound done with SwissADME database, and ADME qualified active compound target were obtained with having probability >0.7 from SwissTargetPrediction database. Target of AML retrieved from GeneCard database having relevancy score ≥5.0. To take the common, target of active compound and AML targets from GeneCard are imported into the Venny2.1 database, and the resulting targets used for the analysis. Cytoscape3.9.1 software was used to construct the "drug-active components-target" network diagram from common targets. The PPI (protein-protein interaction) network between proteins was constructed by STRING and result exported to Cytoscape3.9.1 for network analysis to get subnetwork with key target of subnetwork and core targets of overall PPI. GO (gene ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis of key target from subnetwork done with g-profiler database. Core targets were docked with their corresponding active compound to get docking score. Results Total of 66 active compound were obtained from H. indicus, On ADME screening 49 active compounds qualified. ADME qualified active compound screened for target and 149 target obtained, after removal of duplicates 81 target were remained. 806 targets of AML were screened from GeneCard database. 19 common targets were obtained between target of active compound and target of AML from GeneCard. These screened 19 targets imported in STRING database to construct PPI network, and obtained result imported into Cytoscape3.9.1 for network analysis, on analysis 1 sub networks with 11 key targets were obtained. Top five H. indicus core targets for AML obtained using “CytoHubba” plug-in. GO and KEGG enrichment analyses were performed on the above-mentioned 11 key targets from sub network, 44 MF (Molecular function), 166 BP (Biological process), 12 CC (Cellular component) and 55 pathways were obtained from the KEGG pathway analyses. Molecular docking results showed that the active component quercetin could spontaneously bind to
文摘& # x0D;背景& # x0D;急性髓系白血病(AML)是骨髓系干细胞前体的恶性肿瘤,由于遗传变异而发生。亚洲儿童AML发病率为8.4 / 100万。阿育吠陀对AML没有确切的描述,它可以被认为是Raktapitta(~出血障碍)病。半赤豆(L.)R.Br。(~ H。indicus)用于治疗Raktapitta。AML的主要治疗方法是化疗,患者正在寻找阿育吠陀药物。因此,我们尝试评价红僵菌在AML中的活性。 目标# x0D;利用网络药理学和分子对接研究,建立indicus对AML治疗作用的联系。& # x0D;材料与方法 从植物化学IMPPAT数据库中检索了籼稻根中的有效成分。利用SwissADME数据库对检索到的活性化合物进行ADME(吸收、分布、代谢和排泄)研究,从SwissTargetPrediction数据库获得符合ADME条件的活性化合物靶标,概率为>0.7。从GeneCard数据库检索的AML靶标,相关性评分≥5.0。将GeneCard中常用的活性化合物靶点和AML靶点导入Venny2.1数据库,并将得到的靶点用于分析。利用Cytoscape3.9.1软件从常见靶点构建“药物活性成分-靶点”网络图。通过STRING构建蛋白间的PPI (protein-protein interaction)网络,并将结果导出到Cytoscape3.9.1进行网络分析,得到具有子网络关键靶点和整体PPI核心靶点的子网络。GO (gene ontology)和KEGG (Kyoto Encyclopedia of Genes and Genomes)利用g-profiler数据库对子网络中的关键目标进行通路分析。将核心靶点与其对应的活性化合物对接得到对接分数。 结果# x0D;从籼稻中分离得到66种活性化合物,经ADME筛选,49种活性化合物符合要求。筛选出符合ADME标准的活性化合物,得到靶标149个,去除重复物后剩下81个靶标。从GeneCard数据库中筛选出806个AML靶点。从GeneCard中获得活性化合物靶点与AML靶点之间的19个共同靶点。筛选从STRING数据库中导入的19个靶点构建PPI网络,并将得到的结果导入到Cytoscape3.9.1中进行网络分析,通过分析得到1个包含11个关键靶点的子网络。利用“CytoHubba”插件获得的5个抗AML核心靶点。对上述11个关键靶点进行了GO和KEGG富集分析,从KEGG通路分析中获得44个MF(分子功能)、166个BP(生物过程)、12个CC(细胞成分)和55个通路。分子对接结果表明,活性成分槲皮素能够自发结合核心靶点EGFR、SRC、AKT1、KDR和IGF1R。EGFR与槲皮素的结合效果最佳。 结论& # x0D;通过PPI网络分析鉴定出的核心靶点均与常见活性化合物槲皮素相连,在分子对接研究中,所有核心靶点均与槲皮素有良好的对接得分。因此,基于本研究的结论可以得出,h . indicus是AML的活动可能是由于槲皮素的活性化合物。本研究为印度河嗜血杆菌与AML的有效性建立了联系。
{"title":"Network pharmacology and Molecular docking-based activity of Hemidesmus indicus (L.) R.Br. in Acute myeloid leukemia : A Computational Study","authors":"Vijay kumar Pathak","doi":"10.47552/ijam.v14i3.3883","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3883","url":null,"abstract":"ABSTRACT &#x0D; Background &#x0D; Acute myeloid leukemia (AML) is malignancy of the stem cell precursors of the myeloid lineage occurs due to variations in genetics. Incidence rate of childhood AML in Asian population is 8.4 per million. There is no exact description of AML is Ayurveda, it can be considered into Raktapitta (~bleeding disorder) disease. Hemidesmus indicus (L.) R.Br. (~H. indicus) is described for treatment of Raktapitta. The main treatment for AML is chemotherapy, and patient are searching for Ayurvedic medicines. Hence attempt is made for evaluating activity of H. indicus in AML.&#x0D; Objective&#x0D; To establish link for therapeutic activity of H. indicus in AML using Network pharmacology and molecular docking study. &#x0D; Materials and methods&#x0D; Active compound from root of H. indicus was retrieved from phytochemical based IMPPAT database. ADME (absorption, distribution, metabolism and excretion) study of retrieved active compound done with SwissADME database, and ADME qualified active compound target were obtained with having probability &gt;0.7 from SwissTargetPrediction database. Target of AML retrieved from GeneCard database having relevancy score ≥5.0. To take the common, target of active compound and AML targets from GeneCard are imported into the Venny2.1 database, and the resulting targets used for the analysis. Cytoscape3.9.1 software was used to construct the \"drug-active components-target\" network diagram from common targets. The PPI (protein-protein interaction) network between proteins was constructed by STRING and result exported to Cytoscape3.9.1 for network analysis to get subnetwork with key target of subnetwork and core targets of overall PPI. GO (gene ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis of key target from subnetwork done with g-profiler database. Core targets were docked with their corresponding active compound to get docking score.&#x0D; Results&#x0D; Total of 66 active compound were obtained from H. indicus, On ADME screening 49 active compounds qualified. ADME qualified active compound screened for target and 149 target obtained, after removal of duplicates 81 target were remained. 806 targets of AML were screened from GeneCard database. 19 common targets were obtained between target of active compound and target of AML from GeneCard. These screened 19 targets imported in STRING database to construct PPI network, and obtained result imported into Cytoscape3.9.1 for network analysis, on analysis 1 sub networks with 11 key targets were obtained. Top five H. indicus core targets for AML obtained using “CytoHubba” plug-in. GO and KEGG enrichment analyses were performed on the above-mentioned 11 key targets from sub network, 44 MF (Molecular function), 166 BP (Biological process), 12 CC (Cellular component) and 55 pathways were obtained from the KEGG pathway analyses. Molecular docking results showed that the active component quercetin could spontaneously bind to ","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Ayurvedic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1